Ikaria

Ikaria develops and provides innovative therapies and interventions to meet the significant needs of critically ill patients. Our goal is to become an indispensable partner for clinicians, offering assistance and emergency care when patients need it most. Ikaria focuses on treatment and delivery systems for critically ill infants in hospital settings. The company's main product, Inomax, is used to treat both long-term and acute respiratory issues in newborns.